Provided by Tiger Trade Technology Pte. Ltd.

Atai Beckley Inc

7.38
-0.0400-0.54%
Post-market: 7.30-0.0800-1.08%19:59 EDT
Volume:4.31M
Turnover:31.97M
Market Cap:2.73B
PE:-3.46
High:7.45
Open:7.41
Low:7.38
Close:7.42
52wk High:7.45
52wk Low:3.27
Shares:369.95M
Float Shares:294.14M
Volume Ratio:0.51
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1359
EPS(LYR):-2.9137
ROE:-417.21%
ROA:-39.03%
PB:15.48
PE(LYR):-2.53

Loading ...

Ataibeckley Inc: Files for Mixed Shelf Offering, Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 09

ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection

TIPRANKS
·
Mar 09

Stock Track | Atai Beckley Soars 5.60% in Pre-Market on Analyst Ratings Activity

Stock Track
·
Mar 09

Analysts Conflicted on These Healthcare Names: Biohaven Ltd. (BHVN) and Atai Beckley N.V. (ATAI)

TIPRANKS
·
Mar 09

BRIEF-AtaiBeckley Is Said To Explore Options For Main Psychedelic Drug- Bloomberg News

Reuters
·
Mar 08

Ataibeckley Is Said to Explore Options for Main Psychedelic Drug- Bloomberg News

THOMSON REUTERS
·
Mar 08

Atai Beckley N.V. completes Beckley Psytech acquisition in share deal

Reuters
·
Mar 07

Sector Update: Health Care Stocks Fall Pre-Bell Friday

MT Newswires Live
·
Mar 06

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Fresh Market Data Releases

MT Newswires Live
·
Mar 06

Atai Life Sciences Q4 Operating Expenses USD 571.048 Million

Reuters
·
Mar 06

AtaiBeckley's Q4 loss widens on merger-related R&D costs

Reuters
·
Mar 06

Earnings Flash (ATAI) AtaiBeckley Posts Q4 Loss $1.73 a Share, vs. FactSet Est of $0.09 Loss

MT Newswires Live
·
Mar 06

AtaiBeckley Q4 net loss attributable to stockholders widens 1.3x to USD 544.8 million

Reuters
·
Mar 06

Ataibeckley Inc Q4 EPS $-1.73, REV $1.1 Mln

THOMSON REUTERS
·
Mar 06

Press Release: AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update

Dow Jones
·
Mar 06

Analysts Are Bullish on These Healthcare Stocks: Harrow Health (HROW), Atai Beckley N.V. (ATAI)

TIPRANKS
·
Mar 03

Berenberg Adjusts AtaiBeckley Price Target to $13 From $12, Maintains Buy Rating

MT Newswires Live
·
Mar 03

AtaiBeckley to Host Virtual Investor Day on BPL-003 Phase 3 Clinical Strategy

Reuters
·
Mar 03

Ataibeckley Inc - Aligned With FDA on Phase 3 Program for Bpl-003

THOMSON REUTERS
·
Mar 03

AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression

GlobeNewswire
·
Mar 03